title: MicroRNAs in endometrial cancer.
abstract: MicroRNAs (miRNAs) are small non-coding ribonucleic acids (RNAs) of approximately 22 bp that induce RNA interference with a complementary messenger RNA (mRNA) and act in silencing of mRNA. miRNAs are strongly associated with cancer development and those involved in carcinogenesis are classified into oncogenic miRNAs and tumor suppressor miRNAs (tumor suppressor miRs). Specific miRNAs are expressed in various tissues and changes in regulation of gene expression are thought to cause carcinogenesis. Thus, tissue-specific miRNAs may be biomarkers for cancer diagnosis and prognosis. Approaches to application of miRNAs as cancer therapy are also ongoing, based on the involvement of miRNAs in carcinogenesis. In endometrial cancer, miRNAs are associated with regulation of gene expression, epigenetic dysfunction and carcinogenesis. Thus, miRNAs are likely to have key roles in diagnosis, prognostic prediction, and therapy in endometrial cancer.
authors: Department of Obstetrics and Gynecology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. kbanno@z7.keio.jp
authors: Kouji
authors: K
authors: Banno
authors: Megumi
authors: M
authors: Yanokura
authors: Iori
authors: I
authors: Kisu
authors: Wataru
authors: W
authors: Yamagami
authors: Nobuyuki
authors: N
authors: Susumu
authors: Daisuke
authors: D
authors: Aoki
mesh_terms: D014408:Biomarkers, Tumor; D002471:Cell Transformation, Neoplastic; D016889:Endometrial Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000473:pathology; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D035683:MicroRNAs / Q000235:genetics*; D011379:Prognosis; D012333:RNA, Messenger / Q000235:genetics*
chemical_list: D014408:Biomarkers, Tumor; D035683:MicroRNAs; D012333:RNA, Messenger
references: Oncol Rep. 2012 Aug;28(2):465-72
references: 22641236
references: Int J Cancer. 2012 Mar 1;130(5):1036-45
references: 21400511
references: Clin Cancer Res. 2012 Jun 1;18(11):3054-70
references: 22452939
references: Cancer J. 2012 May-Jun;18(3):215-22
references: 22647357
references: Biol Reprod. 2010 Apr;82(4):653-5
references: 20130265
references: Cancer Res. 2011 Oct 15;71(20):6450-62
references: 21868754
references: Biol Reprod. 2010 Apr;82(4):791-801
references: 19864316
references: Oncol Lett. 2010 Nov;1(6):935-940
references: 22870090
references: Oncol Rep. 2012 Aug;28(2):592-600
references: 22614869
references: J Cancer Res Clin Oncol. 2012 Oct;138(10):1659-66
references: 22638884
references: Oncol Rep. 2012 Mar;27(3):807-12
references: 22139444
references: Anticancer Res. 2011 Dec;31(12):4083-9
references: 22199265
references: Eur J Cancer Prev. 2009 Feb;18(1):50-5
references: 19077565
references: Med Oncol. 2012 Dec;29(5):3472-7
references: 22644918
references: Reprod Sci. 2008 Dec;15(10):993-1001
references: 19088369
references: Cytotechnology. 2011 Jan;63(1):67-80
references: 21188518
references: Nature. 2000 Feb 24;403(6772):901-6
references: 10706289
references: Cancer Res. 2008 Jun 1;68(11):4123-32
references: 18519671
references: J Clin Endocrinol Metab. 2011 Dec;96(12):E1925-33
references: 21956427
references: Cancer Res. 2009 Dec 1;69(23):9038-46
references: 19887623
references: Cancer Lett. 2013 Sep 10;338(1):174-83
references: 22554710
references: Cancer J. 2012 May-Jun;18(3):268-74
references: 22647364
references: Int J Cancer. 2012 Aug 15;131(4):E395-404
references: 22052540
references: J Clin Endocrinol Metab. 2012 Aug;97(8):E1515-23
references: 22648654
references: Genes Cancer. 2011 Jul;2(7):720-7
references: 22207897
references: Med Sci Monit. 2012 Apr;18(4):BR149-55
references: 22460089
references: Mol Pharm. 2012 Jun 4;9(6):1638-44
references: 22574727
references: BMC Cancer. 2011 Oct 05;11:425
references: 21970405
references: PLoS One. 2011;6(12):e29043
references: 22194984
references: Eur J Pharmacol. 2012 Jun 5;684(1-3):8-18
references: 22484336
references: Int J Cancer. 2009 Mar 15;124(6):1358-65
references: 19065659
references: Mol Cancer. 2011 Aug 18;10:99
references: 21851624
references: Clin Cancer Res. 2012 Jul 15;18(14):3982-91
references: 22661538
references: Gynecol Oncol. 2008 Aug;110(2):206-15
references: 18499237
references: Clin Chem. 2012 Mar;58(3):610-8
references: 22194634
references: Int J Biochem Cell Biol. 2012 Sep;44(9):1465-72
references: 22642900
references: PLoS One. 2012;7(5):e36306
references: 22606253
references: J Steroid Biochem Mol Biol. 2011 Sep;126(3-5):113-20
references: 21168492
references: Lung Cancer. 2012 Apr;76(1):32-8
references: 22047961
references: PLoS One. 2012;7(4):e35158
references: 22514717
references: Epigenomics. 2012 Apr;4(2):147-62
references: 22449187